tiprankstipranks
Trending News
More News >
SAB Biotherapeutics (SABS)
NASDAQ:SABS
US Market

SAB Biotherapeutics (SABS) Similar Stocks

Compare
139 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
SAB Biotherapeutics
$1.39
$12.82M
-68.80%
3 Buy
0 Hold
0 Sell
Strong Buy
Fate Therapeutics
$1.11
$128.36M
-77.98%
4 Buy
8 Hold
0 Sell
Moderate Buy
Replimune Group
$8.00
$593.78M
10.89%
7 Buy
0 Hold
0 Sell
Strong Buy
Allogene Therapeutics
$1.45
$315.03M
-58.69%
11 Buy
1 Hold
0 Sell
Strong Buy
Adaptive Biotechnologies
$7.33
$1.15B
200.41%
6 Buy
1 Hold
0 Sell
Strong Buy
Immatics
$4.11
$531.17M
50.99
-58.48%
3 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
SABS
SAB Biotherapeutics
1.44
-3.02
-67.71%
FATE
Fate Therapeutics
1.11
-3.93
-77.98%
REPL
Replimune Group
8.00
1.03
14.78%
ALLO
Allogene Therapeutics
1.45
-2.01
-58.09%
ADPT
Adaptive Biotechnologies
7.33
4.99
213.25%
IMTX
Immatics
4.26
-6.00
-58.48%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis